SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: mesaone who wrote (213)6/26/1998 11:16:00 AM
From: Steve Lokness  Respond to of 337
 
As many biotechs are doing so poorly, could it be managers looking for a winner to have in their portfolio before the end of the quarter?

There was also an article, I think yesterday highlighting the importance of HIV that develop resistances and the importance of identify the resistant strains - wish I could remember where I saw that.

Steve



To: mesaone who wrote (213)6/26/1998 11:54:00 AM
From: Rod Gilchrist  Read Replies (1) | Respond to of 337
 
Richard wrote earlier:

> They'll also be presenting at Cruttenden Roth, so they'll
> be getting attention in Geneva and New York at about the
> same time........

I think he meant to watch the World HIV Conference
that opens monday in Geneva.

Our last major show was ICAAC in Toronto September 28
to October 1, 1997.

- Rod


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News